MeasurableQuantitativeAnnotation  

PubMed:32240670 JSONTXT 10 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
N3 656-660 num denotes 71±8
U2 661-666 unit denotes years
N2 667-670 num denotes 173
E1 671-678 entity denotes females
N1 680-682 num denotes 51
U1 682-683 unit denotes %
N4 711-713 num denotes 80
N5 715-719 num denotes 23.6
U3 719-720 unit denotes %
E2 722-730 entity denotes critical
N6 732-735 num denotes 159
E3 736-742 entity denotes severe
N7 744-748 num denotes 46.9
U4 748-749 unit denotes %
N8 755-758 num denotes 100
E4 759-767 entity denotes moderate
N9 769-773 num denotes 29.5
U5 773-774 unit denotes %
U6 776-781 unit denotes cases
E1 809-821 entity denotes hypertension
N1 823-827 num denotes 40.8
U1 827-828 unit denotes %
E2 831-839 entity denotes diabetes
N2 841-845 num denotes 16.0
U2 845-846 unit denotes %
E3 852-874 entity denotes cardiovascular disease
N3 876-880 num denotes 15.7
U3 880-881 unit denotes %
E1 909-914 entity denotes fever
N1 916-920 num denotes 92.0
U1 920-921 unit denotes %
E2 924-929 entity denotes cough
N2 931-935 num denotes 53.0
U2 935-936 unit denotes %
E3 939-946 entity denotes dyspnea
N3 948-952 num denotes 40.8
U3 952-953 unit denotes %
E4 959-966 entity denotes fatigue
N4 968-972 num denotes 39.9
U4 972-973 unit denotes %
E1 976-991 entity denotes Lymphocytopenia
N1 1025-1029 num denotes 63.2
U1 1029-1030 unit denotes %
E1 1063-1082 entity denotes bacterial infection
N1 1084-1088 num denotes 42.8
U1 1088-1089 unit denotes %
E2 1092-1118 entity denotes liver enzyme abnormalities
N2 1120-1124 num denotes 28.7
U2 1124-1125 unit denotes %
E3 1131-1166 entity denotes acute respiratory distress syndrome
N3 1168-1172 num denotes 21.0
U3 1172-1173 unit denotes %
N1 1279-1283 num denotes 19.2
U1 1283-1284 unit denotes %
E1 1291-1295 entity denotes dead
R1 E1 N3 associateWith dead,21.0
R1 E1 N1 associateWith dead,19.2
R1 E1 N1 associateWith dead,19.2
R1 E1 N1 associateWith dead,19.2
R1 E1 N1 associateWith dead,19.2
R1 E1 N1 associateWith dead,19.2
R10 E3 N7 associateWith acute respiratory distress syndrome,46.9
R11 N7 U4 associateOf 46.9,%
R12 E4 N8 associateWith fatigue,100
R13 E4 N9 associateWith fatigue,29.5
R14 N9 U5 associateOf 29.5,%
R15 N8 U6 associateOf 100,cases
R2 N3 U2 associateOf 21.0,%
R2 N1 U1 associateOf 19.2,%
R2 N1 U1 associateOf 19.2,%
R2 N1 U1 associateOf 19.2,%
R2 N1 U1 associateOf 19.2,%
R2 N1 U1 associateOf 19.2,%
R3 E1 N2 associateWith dead,28.7
R3 E2 N2 associateWith liver enzyme abnormalities,28.7
R3 E2 N2 associateWith liver enzyme abnormalities,28.7
R3 E2 N2 associateWith liver enzyme abnormalities,28.7
R4 E1 N1 associateWith dead,19.2
R4 N2 U2 associateOf 28.7,%
R4 N2 U2 associateOf 28.7,%
R4 N2 U2 associateOf 28.7,%
R5 N1 U1 associateOf 19.2,%
R5 E3 N3 associateWith acute respiratory distress syndrome,21.0
R5 E3 N3 associateWith acute respiratory distress syndrome,21.0
R5 E3 N3 associateWith acute respiratory distress syndrome,21.0
R6 E2 N4 associateWith liver enzyme abnormalities,39.9
R6 N3 U3 associateOf 21.0,%
R6 N3 U3 associateOf 21.0,%
R6 N3 U3 associateOf 21.0,%
R7 E2 N5 associateWith liver enzyme abnormalities,23.6
R7 E4 N4 associateWith fatigue,39.9
R8 N5 U3 associateOf 23.6,%
R8 N4 U4 associateOf 39.9,%
R9 E3 N6 associateWith acute respiratory distress syndrome,159